"Incomplete lupus" is a term used to describe a person who has some symptoms of lupus but not enough to make the diagnosis ...

Patients with SLE have a higher prevalence of primary headaches vs those with RA or pSS, but similar percentages were found when comparing healthy controls.

Controlling cardiovascular risk factors and maintaining long-term disease remission mitigated the increased risk for ...

ALM-223 is under development for the treatment of systemic lupus erythematosus (SLE) and atopic dermatitis (AD). It is administered through subcutaneous route in the form of liquid. It is a fusion ...

The antiviral drug valaciclovir (Valtrex), given prophylactically, kept patients with systemic lupus erythematosus (SLE) ...

We described the first case reported in the literature of multiple myeloma in a young African woman with Systemic lupus and Sjögren Syndrome. The clinician should consider multiple myeloma in young ...

Atherosclerosis progression was more than twice as common in younger people with systemic lupus erythematosus (SLE) than in ...

The prevalence of fibromyalgia is higher among patients with SLE vs the general population, adding to an already significant ...

IGM Biosciences (IGMS) is slashing its workforce by 73% and discontinuing development of two of its lead drug candidates in ...

Staff cuts could leave IGM Biosciences with fewer than 55 employees. The company is also halting development of two ...

IGM Biosciences (IGMS) announced a strategic update to halt further development of imvotamab, an IgM-based CD20 X CD3 bispecific antibody T ...